Variable | Categories | N | % | % Valid | After MI |
---|---|---|---|---|---|
Sex | Women | 268 | 14.0 | 14.0 | |
Men | 1646 | 86.0 | 86.0 | ||
Age | 15–44 | 45 | 2.4 | 2.4 | |
45–54 | 172 | 9.0 | 9.0 | ||
55–64 | 445 | 23.2 | 23.2 | ||
65–74 | 548 | 30.2 | 30.2 | ||
75 or + | 674 | 35.2 | 35.2 | ||
Diagnostic method | Pathological | 1843 | 96.3 | 96.3 | |
Clinical | 65 | 3.4 | 3.4 | ||
Unknown | 6 | 0.3 | 0.3 | ||
Histology | Papillary transitional neoplasia | 1096 | 57.3 | 57.3 | |
Solid transitional neoplasia | 713 | 37.3 | 37.3 | ||
Other histology and unspecified | 105 | 5.5 | 5.5 | ||
Behaviour | Invasive | 1160 | 60.6 | 60.6 | |
In situ | 680 | 35.5 | 35.5 | ||
Uncertain | 74 | 3.9 | 3.9 | ||
Clinical or pathological tumour size (T_PT) | 1 | 566 | 29.6 | 44.0 | |
2 | 207 | 10.8 | 16.1 | ||
3 | 68 | 3.6 | 5.3 | ||
4a | 58 | 3.0 | 4.5 | ||
4b | 1 | 0.1 | 0.1 | ||
a (histology 8130 and behaviour in situ) | 298 | 15.6 | 23.2 | ||
is (histology 8120 and behaviour in situ) | 13 | 0.7 | 1.0 | ||
uncertain behaviour | 74 | 3.9 | 5.8 | ||
Missing | 629 | 32.9 | |||
Clinical or pathological regional lymph nodes (N_PN) | 0 | 187 | 8.8 | 68.8 | |
1 | 33 | 1.7 | 12.1 | ||
2 | 46 | 2.4 | 16.9 | ||
3 | 6 | 0.3 | 2.2 | ||
Missing | 1642 | 85.8 | |||
Metastasis(M) | 0 | 237 | 12.4 | 80.6 | |
1 | 57 | 3.0 | 19.4 | ||
Missing | 1620 | 84.6 | |||
Stagea | Ta | 625 | 32.7 | 38.6 | 37.3 |
Tis | 53 | 2.8 | 3.3 | 3.2 | |
I | 564 | 29.5 | 34.8 | 34.2 | |
II | 181 | 9.5 | 11.2 | 11.8 | |
III | 67 | 3.5 | 4.1 | 4.3 | |
IV | 129 | 6.7 | 8.0 | 9.1 | |
No stage | 74 | 3.9 | |||
Missing | 221 | 11.5 |